Friends of Science in Medicine
A $200 million gift promotes alternative therapies at a California medical school — and critics recoil: “The couple has been promoting and funding research into alternative medicine for years … [including] the efficacy of prayer and homeopathy as a … [Read more...]
Uber driver protesting ‘Vaxxed’ film meets Philly vaccine pioneer: Craig Egan drove across the country this summer to disrupt a bus tour launched by the makers of the film Vaxxed, a group that questions the safety of vaccines. The … [Read more...]
Cancer, vitamin supplements, and unexpected consequences: Not only do B-vitamin supplements not protect you from lung cancer, they may significantly raise your risk of cancer.
Naturopathic Cancer Quackery: Naturopaths treat cancer with an array of implausible concoctions … [Read more...]
Comment on the (FDA) Notice: Draft Revisions to the FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioids; Availability; “Recommendations by the FDA (US) impact all countries. FSM appreciates that it is appropriate for the FDA to recommend … [Read more...]
Chiros to lose spinal X-ray Medicare rebates: Chiropractors will lose access to Medicare items for spinal X-rays for low back pain as part of the government’s implementation of the MBS Review Taskforce recommendation.
Are drug expiry dates really a myth?: “There’s no single rule for expired drugs and supplements, owing to the variety of products, regulatory requirements, and other factors that can influence a product’s safety and efficacy. In general, expiry dates … [Read more...]
New complementary medicine health claims lack evidence, so why are they even on the table? Australia’s drugs regulator seems to be endorsing pseudoscientific claims about homeopathy and traditional Chinese medicine as part of its review of how complementary medicines are … [Read more...]
King Review: Homeopathy shouldn’t be sold in PBS-approved pharmacies: FSM’s Ian Carr has welcomed King Review recommendations on homeopathy .The interim report of the Review of Pharmacy Remuneration and Regulation states that “there are unacceptable risks where community pharmacies are allowed … [Read more...]
Comment on the (FDA) Notice: Draft Revisions to the FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioids; Availability; “Recommendations by the FDA (US) impact all countries. FSM appreciates that it is appropriate for the FDA to recommend … [Read more...]